| Factor Information | |
|---|---|
| Data ID | 3816 |
| Factor | hospital stays |
| Description | Patients with diastolic flow reversal who survived had longer intensive care unit (26.2 +/- 13.5 days vs 7.1 +/- 4.1 days, P <.001) and hospital (57.4 +/- 38.8 days vs 14.8 +/- 5.2 days, P <.05) stays. |
| Biomarker | NA |
| Classification | A12 (clinical factor - treatment) |
| Association | |
|---|---|
| Application | prognosis and risk assessment |
| Objective | To determine whether mid-diastolic flow reversal predicts outcome in patients undergoing repair or palliation of neonatal congenital heart disease |
| p Value | <0.05 |
| Conclusion | Patients with diastolic flow reversal who survived had longer intensive care unit (26.2 +/- 13.5 days vs 7.1 +/- 4.1 days, P <.001) and hospital (57.4 +/- 38.8 days vs 14.8 +/- 5.2 days, P <.05) stays. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 711 |
| CHD Type | isolated CHD |
| CHD Subtype | TGA/CoA/IAA/AS |
| Reference | |
|---|---|
| PMID | 9842023 |
| Year | 1998 |
| Title | Abnormal left ventricular filling after neonatal repair of congenital heart disease: Association with increased mortality and morbidity |
| Sample | ||
|---|---|---|
| Population | neonates | |
| Source | cohort | |
| Region | NC, USA | |
| Method | echocardiograms and medical records | |
| Race | North America | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | MDFR (patients with mid-diastolic flow reversal)(Treatment) | No MDFR (patients without mid-diastolic flow reversal)(Control) |
| Number | 14 | 19 |
| Age | 2 to 21 days (mean 11.3 ± 5.4 days) | 2 to 21 days (mean 11.3 ± 5.4 days) |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | 57.4 ± 38.8 days | 14.8 ± 5.2 days |
